title: Rhabdomyolysis-induced acute renal failure following fenofibrate therapy: a case report and literature review.
abstract: Fenofibrate, a fibric acid derivative, is used to treat diabetic dyslipidemia, hypertriglyceridemia, and combined hyperlipidemia, administered alone or in combination with statins. Rhabdomyolysis is defined as a pathological condition involving skeletal muscle cell damage leading to the release of toxic intracellular material into circulation. Its major causes include muscle compression or overexertion; trauma; ischemia; toxins; cocaine, alcohol, and drug use; metabolic disorders; infections. However, rhabdomyolysis associated with fenofibrate is extremely rare. Herein we report a 45-year-old female patient who was referred to our department because of generalized muscle pain, fatigue, weakness, and oliguria over the preceding 3 weeks. On the basis of the pathogenesis and clinical and laboratory examinations, a diagnosis of acute renal failure secondary to fenofibrate-induced rhabdomyolysis was made. Weekly followups for patients who are administered fenofibrate are the most important way to prevent possible complications.
authors.affiliation: Department of Nephrology, Diyarbakir Education and Research Hospital, 21400 Diyarbakir, Turkey.
authors.forename: Ramazan
authors.initials: R
authors.lastname: Danis
authors.forename: Sami
authors.initials: S
authors.lastname: Akbulut
authors.forename: Sehmus
authors.initials: S
authors.lastname: Ozmen
authors.forename: Senay
authors.initials: S
authors.lastname: Arikan
references.citation: J Am Soc Nephrol. 2000 Aug;11(8):1553-1561
references.pmid: 10906171
references.citation: Ann Intern Med. 2005 Jun 7;142(11):949-50
references.pmid: 15941707
references.citation: Diabetes Care. 2003 Aug;26(8):2482-3
references.pmid: 12882895
references.citation: Drug Metabol Drug Interact. 2007;22(4):279-83
references.pmid: 18447003
references.citation: Arq Bras Endocrinol Metabol. 2009 Apr;53(3):383-6
references.pmid: 19578603
references.citation: J Assoc Physicians India. 2007 Feb;55:152-3
references.pmid: 17571748
references.citation: Eur J Clin Pharmacol. 2009 Dec;65(12):1169-74
references.pmid: 19756555
references.citation: Ren Fail. 2007;29(7):927-30
references.pmid: 17994463
references.citation: Diabetes Care. 2005 May;28(5):1258
references.pmid: 15855605
references.citation: Clin Pharmacol Ther. 1981 Aug;30(2):239-45
references.pmid: 7249508
references.citation: Nephrol Dial Transplant. 1999 Apr;14(4):1047-8
references.pmid: 10328516
references.citation: Medicine (Baltimore). 2005 Nov;84(6):377-385
references.pmid: 16267412
references.citation: Clin Nephrol. 2005 Nov;64(5):391-3
references.pmid: 16312269
references.citation: Acta Cardiol. 2008 Aug;63(4):515-7
references.pmid: 18795591
references.citation: Arch Argent Pediatr. 2008 Oct;106(5):454-7
references.pmid: 19030648
references.citation: Intern Med. 2008;47(11):1017-9
references.pmid: 18520113
references.citation: Indian J Med Sci. 2008 Nov;62(11):458-9
references.pmid: 19265237
references.citation: Neurol India. 2004 Jun;52(2):268-9
references.pmid: 15269493